Lorcaserin (Belviq): A selective serotonin 5-HT2C agonist in the treatment of obesity

Ashley Gustafson; Camille King; Jose A. Rey

Lorcaserin (Belviq): A selective serotonin 5-HT_2C agonist in the treatment of obesity

Ashley Gustafson
, Camille King
, Jose A. Rey

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	525-530+534
Journal	P and T
Volume	38
Issue number	9
State	Published - Sep 2013

ASJC Scopus Subject Areas

Pharmacology (medical)

Disciplines

Medical Pharmacology

Access to Document

https://pmc.ncbi.nlm.nih.gov/articles/PMC3828930/

Cite this

@article{8d0a6b189bdb47cb81c7101807e0ff8a,

title = "Lorcaserin (Belviq): A selective serotonin 5-HT2C agonist in the treatment of obesity",

author = "Ashley Gustafson and Camille King and Rey, \{Jose A.\}",

year = "2013",

month = sep,

language = "English",

volume = "38",

pages = "525--530+534",

journal = "P and T",

issn = "1052-1372",

publisher = "MediMedia USA Inc.",

number = "9",

}

TY - JOUR

T1 - Lorcaserin (Belviq)

T2 - A selective serotonin 5-HT2C agonist in the treatment of obesity

AU - Gustafson, Ashley

AU - King, Camille

AU - Rey, Jose A.

PY - 2013/9

Y1 - 2013/9

UR - https://www.scopus.com/pages/publications/84884190786

UR - https://www.scopus.com/pages/publications/84884190786#tab=citedBy

M3 - Comment/debate

AN - SCOPUS:84884190786

SN - 1052-1372

VL - 38

SP - 525-530+534

JO - P and T

JF - P and T

IS - 9

ER -